Improved survival after LTx-associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single-center experience and systematic review

Autor: Minnee, R.C., Fieuws, S., Jochmans, I., Aerts, R., Sainz Barriga, M., Debaveye, Y., Maertens, J., Vandenberghe, P., Laleman, W., van der Merwe, S., Verslype, C., Cassiman, D., Ferdinande, P., Nevens, F., Pirenne, J., Monbaliu, D. *
Zdroj: In American Journal of Transplantation December 2018 18(12):3007-3020
Databáze: ScienceDirect
Externí odkaz: